Tacke F - Search Results

1

Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.

Krenkel O, Puengel T, Govaere O, Abdallah AT, Mossanen JC, Kohlhepp M, Liepelt A, Lefebvre E, Luedde T, Hellerbrand C, Weiskirchen R, Longerich T, Costa IG, Anstee QM, Trautwein C, Tacke F. Krenkel O, et al. Among authors: tacke f. Hepatology. 2018 Apr;67(4):1270-1283. doi: 10.1002/hep.29544. Epub 2018 Feb 19. Hepatology. 2018. PMID: 28940700

2

Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease.

Tacke F, Schöffski P, Trautwein C, Manns MP, Ganser A, von Depka M. Tacke F, et al. Blood Coagul Fibrinolysis. 2001 Oct;12(7):539-45. doi: 10.1097/00001721-200110000-00005. Blood Coagul Fibrinolysis. 2001. PMID: 11685041

3

Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis.

Tacke F, Trautwein C, Zhao S, Andreeff M, Manns MP, Ganser A, Schöffski P. Tacke F, et al. Liver. 2002 Jun;22(3):205-12. doi: 10.1034/j.1600-0676.2002.01642.x. Liver. 2002. PMID: 12100570

4

Ghrelin in chronic liver disease.

Tacke F, Brabant G, Kruck E, Horn R, Schöffski P, Hecker H, Manns MP, Trautwein C. Tacke F, et al. J Hepatol. 2003 Apr;38(4):447-54. doi: 10.1016/s0168-8278(02)00438-5. J Hepatol. 2003. PMID: 12663236

5

p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.

Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C. Luedde T, et al. Among authors: tacke f. Hepatology. 2003 Apr;37(4):833-41. doi: 10.1053/jhep.2003.50136. Hepatology. 2003. PMID: 12668976

6

[Treatment of hepatitis B and C virus infection].

Trautwein C, Tacke F. Trautwein C, et al. Among authors: tacke f. Dtsch Med Wochenschr. 2003 Jun 13;128 Suppl 2:S87-9. doi: 10.1055/s-2003-40144. Dtsch Med Wochenschr. 2003. PMID: 12817332 Review. German. No abstract available.

7

Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.

Streetz KL, Tacke F, Leifeld L, Wüstefeld T, Graw A, Klein C, Kamino K, Spengler U, Kreipe H, Kubicka S, Müller W, Manns MP, Trautwein C. Streetz KL, et al. Among authors: tacke f. Hepatology. 2003 Jul;38(1):218-29. doi: 10.1053/jhep.2003.50268. Hepatology. 2003. PMID: 12830005

8

Plasma P-selectin levels are elevated in patients with chronic liver disease.

Tacke F, Schöffski P, Trautwein C, Luedde T, Ganser A, Manns MP, von Depka M. Tacke F, et al. Blood Coagul Fibrinolysis. 2003 Jun;14(4):319-25. doi: 10.1097/00001721-200306000-00001. Blood Coagul Fibrinolysis. 2003. PMID: 12945872

9

Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.

Tacke F, Schöffski P, Luedde T, Meier PN, Ganser A, Manns MP, Trautwein C. Tacke F, et al. Scand J Gastroenterol. 2004 Mar;39(3):259-66. doi: 10.1080/00365520310008340. Scand J Gastroenterol. 2004. PMID: 15074396

10

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C. Tacke F, et al. J Virol. 2004 Aug;78(16):8524-35. doi: 10.1128/JVI.78.16.8524-8535.2004. J Virol. 2004. PMID: 15280461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters